HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Palma Dileo Selected Research
Palma Dileo Research Topics
Disease
12
Sarcoma (Soft Tissue Sarcoma)
11/2020 - 05/2007
7
Neoplasms (Cancer)
03/2023 - 05/2009
2
Disease Progression
03/2023 - 11/2020
2
Fatigue
03/2023 - 01/2020
2
Aggressive Fibromatosis (Desmoid)
03/2023 - 08/2015
2
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2014 - 05/2009
2
Genetic Translocation (Chromosomal Translocation)
08/2009 - 07/2007
1
Pain (Aches)
03/2023
1
Hypophosphatemia
03/2023
1
Nausea
03/2023
1
Exanthema (Rash)
03/2023
1
Diarrhea
03/2023
1
Ewing Sarcoma (Sarcoma, Ewing)
01/2022
1
Neoplasm Metastasis (Metastasis)
01/2021
1
COVID-19
07/2020
1
Weight Loss (Weight Reduction)
01/2020
1
Stomatitis
01/2020
1
Hypertension (High Blood Pressure)
01/2020
1
Fibroma (Fibromatosis)
08/2015
1
Synovial Sarcoma (Synovioma)
07/2015
1
Margins of Excision
01/2014
1
Metabolic Diseases (Metabolic Disease)
01/2014
1
Spontaneous Fractures (Pathological Fracture)
04/2013
1
Bone Diseases (Bone Disease)
04/2013
1
Peripheral Primitive Neuroectodermal Tumors (Peripheral Neuroectodermal Tumor)
07/2010
1
Chromosome Aberrations (Chromosome Abnormalities)
07/2010
1
Neuroectodermal Tumors (Neuroectodermal Tumor)
07/2010
1
Hematologic Neoplasms (Hematological Malignancy)
08/2009
1
Myxoid Liposarcoma
07/2007
1
Liposarcoma
07/2007
1
Carcinoma (Carcinomatosis)
05/2007
Drug/Important Bio-Agent (IBA)
3
Ifosfamide
FDA Link
Generic
11/2020 - 09/2012
2
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2020 - 09/2012
2
Imatinib Mesylate (Gleevec)
FDA Link
01/2020 - 02/2011
2
Tyrosine Kinase Inhibitors
IBA
01/2020 - 01/2014
2
Trabectedin
IBA
07/2015 - 07/2007
1
nirogacestat
IBA
03/2023
1
Amyloid Precursor Protein Secretases (beta-Secretase)
IBA
03/2023
1
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
01/2021
1
tazemetostat
IBA
11/2020
1
Sunitinib (Sutent)
FDA Link
01/2020
1
olaratumab
IBA
01/2020
1
cabozantinib
IBA
01/2020
1
beta Catenin
IBA
08/2015
1
Formaldehyde (Formol)
FDA Link
08/2015
1
DNA (Deoxyribonucleic Acid)
IBA
08/2015
1
Paraffin
IBA
08/2015
1
Anthracyclines
IBA
07/2015
1
Glucose (Dextrose)
FDA Link
Generic
01/2014
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
01/2014
1
regorafenib
IBA
01/2014
1
Diphosphonates (Bisphosphonates)
IBA
04/2013
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
09/2012
1
Vincristine (Oncovin)
FDA Link
Generic
09/2012
1
Etoposide (VP 16)
FDA Link
Generic
09/2012
1
Transcription Factors (Transcription Factor)
IBA
07/2010
1
Contrast Media
IBA
05/2009
1
Complement System Proteins (Complement)
IBA
05/2009
1
Proteins (Proteins, Gene)
FDA Link
07/2007
1
Vinorelbine (Navelbine)
FDA Link
Generic
05/2007
1
Gemcitabine
FDA Link
05/2007
Therapy/Procedure
5
Therapeutics
01/2022 - 02/2011
4
Drug Therapy (Chemotherapy)
01/2022 - 05/2009
2
Radiotherapy
04/2013 - 05/2009
1
Aftercare (After-Treatment)
01/2020
1
Drug Tapering
01/2020
1
Palliative Care (Palliative Therapy)
07/2015
1
Adjuvant Chemotherapy
01/2014
1
Combination Drug Therapy (Combination Chemotherapy)
05/2007